Cargando…
Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts
Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy sympt...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841232/ https://www.ncbi.nlm.nih.gov/pubmed/34776462 http://dx.doi.org/10.2176/nmc.oa.2020-0439 |
_version_ | 1784650791760429056 |
---|---|
author | MIYAHARA, Takahiro HATTORI, Gohsuke UCHIKADO, Hisaaki KAKU, Yasuyuki OHMORI, Yuki ORITO, Kimihiko TAKEUCHI, Yasuharu KAWANO, Takayuki HIROHATA, Masaru MUKASA, Akitake MORIOKA, Motohiro |
author_facet | MIYAHARA, Takahiro HATTORI, Gohsuke UCHIKADO, Hisaaki KAKU, Yasuyuki OHMORI, Yuki ORITO, Kimihiko TAKEUCHI, Yasuharu KAWANO, Takayuki HIROHATA, Masaru MUKASA, Akitake MORIOKA, Motohiro |
author_sort | MIYAHARA, Takahiro |
collection | PubMed |
description | Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease. |
format | Online Article Text |
id | pubmed-8841232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japan Neurosurgical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-88412322022-02-25 Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts MIYAHARA, Takahiro HATTORI, Gohsuke UCHIKADO, Hisaaki KAKU, Yasuyuki OHMORI, Yuki ORITO, Kimihiko TAKEUCHI, Yasuharu KAWANO, Takayuki HIROHATA, Masaru MUKASA, Akitake MORIOKA, Motohiro Neurol Med Chir (Tokyo) Original Article Spinal arteriovenous (AV) shunts are rare conditions that sometimes present with myelopathy symptoms. The progression of the symptoms is usually gradual; however, some cases show rapid deterioration. We retrospectively investigated the factors that induced the rapid deterioration of myelopathy symptoms in patients with spinal AV shunts. We treated 33 patients with myelopathy with spinal AV shunts at our institutions, eight of whom experienced rapid deterioration (within 24 hours: 24.2%). Of these, three were related to the body movement or particular postures associated with playing golf, 30 minutes of Japanese straight sitting, and massage care. One patient showed deterioration after embolization for a tracheal aneurysm. The remaining four patients received steroid pulse therapy (high-dose steroid infusion) shortly before the rapid deterioration. These symptoms stopped progressing after cessation of steroid use. While positional or physical factors contributing to myelopathy deterioration might exist, we could not identify specific factors in this study. Nevertheless, rapid deterioration was frequently observed after high-dose steroid use. We must take care not to administer high-dose steroids for myelopathy caused by spinal AV shunt disease. The Japan Neurosurgical Society 2022-01 2021-11-12 /pmc/articles/PMC8841232/ /pubmed/34776462 http://dx.doi.org/10.2176/nmc.oa.2020-0439 Text en © 2022 The Japan Neurosurgical Society https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Original Article MIYAHARA, Takahiro HATTORI, Gohsuke UCHIKADO, Hisaaki KAKU, Yasuyuki OHMORI, Yuki ORITO, Kimihiko TAKEUCHI, Yasuharu KAWANO, Takayuki HIROHATA, Masaru MUKASA, Akitake MORIOKA, Motohiro Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title | Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title_full | Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title_fullStr | Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title_full_unstemmed | Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title_short | Factors Associated with Rapidly Deteriorating Myelopathy in Patients with Spinal Arteriovenous Shunts |
title_sort | factors associated with rapidly deteriorating myelopathy in patients with spinal arteriovenous shunts |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841232/ https://www.ncbi.nlm.nih.gov/pubmed/34776462 http://dx.doi.org/10.2176/nmc.oa.2020-0439 |
work_keys_str_mv | AT miyaharatakahiro factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT hattorigohsuke factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT uchikadohisaaki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT kakuyasuyuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT ohmoriyuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT oritokimihiko factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT takeuchiyasuharu factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT kawanotakayuki factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT hirohatamasaru factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT mukasaakitake factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts AT moriokamotohiro factorsassociatedwithrapidlydeterioratingmyelopathyinpatientswithspinalarteriovenousshunts |